Insights

Join the discussion already in progress as we shift gears from last week’s installment on “Utilization Management: How to achieve best practices in the managed…

We are building on the ongoing discussion about the topics that matter to health plans right now. It started with “…

On November 20, 2020, the Trump administration finalized rules aimed at reducing the costs of drugs. Michael Kolodij, PharmD, unpacks both: “Most Favored…

New opportunity to proactively manage the total cost of diabetes care with integrated data on the powerful Artemetrx technology platform PLANO, Texas–(BUSINESS…

Diabetes is a top category of spend for most plan sponsors. According to the American Diabetes Association, people diagnosed with diabetes incur average medical…

Join the discussion already in progress as we shift gears from last week’s installment on “Unpacking utilization and medical pharmacy integration” to this…

Another double-digit increase (13.6%) in per member per year cost underscores the need for close monitoring and management of specialty. Successfully partnering with health…

Thinking back to one year ago, when writing this commentary on the upcoming 2020 formulary changes, no one could have foreseen the challenges and…

Actionable insights for specialty drug cost savings delivered in PSG’s fourth annual integrated pharmacy and medical benefit report PLANO, Texas–(BUSINESS WIRE)–Pharmaceutical Strategies Group (PSG)…